News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
220,731 Results
Type
Article (4976)
Company Profile (22)
Press Release (215733)
Section
Business (82208)
Career Advice (460)
Deals (15039)
Drug Delivery (8)
Drug Development (19067)
Employer Resources (30)
FDA (3674)
Job Trends (3896)
News (120119)
Policy (7506)
Tag
Academia (290)
Alliances (14714)
Alzheimer's disease (212)
Approvals (3668)
Bankruptcy (94)
Best Places to Work (2831)
Biotechnology (24)
Breast cancer (21)
Cancer (201)
Career advice (391)
Cell therapy (44)
Clinical research (15605)
Collaboration (68)
Compensation (58)
COVID-19 (295)
C-suite (31)
Data (216)
Diagnostics (2002)
Earnings (39572)
Employer resources (31)
Events (36762)
Executive appointments (106)
FDA (3766)
Funding (67)
Gene therapy (22)
GLP-1 (94)
Government (406)
Healthcare (4997)
Infectious disease (304)
Inflammatory bowel disease (21)
Interviews (53)
IPO (7725)
Job creations (1119)
Job search strategy (360)
Layoffs (95)
Legal (2323)
Lung cancer (23)
Manufacturing (24)
Medical device (3811)
Medtech (3812)
Mergers & acquisitions (7333)
Metabolic disorders (56)
Neuroscience (249)
NextGen Class of 2024 (1671)
Non-profit (722)
Northern California (420)
Obesity (31)
Opinion (28)
People (24099)
Phase I (4648)
Phase II (6779)
Phase III (5387)
Pipeline (105)
Postmarket research (625)
Preclinical (1822)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (30)
Real estate (1868)
Regulatory (4973)
Research institute (298)
Resumes & cover letters (68)
Southern California (308)
Startups (1005)
United States (3509)
Vaccines (24)
Date
Today (54)
Last 7 days (266)
Last 30 days (795)
Last 365 days (11243)
2024 (9452)
2023 (13195)
2022 (18670)
2021 (19690)
2020 (18251)
2019 (13212)
2018 (10214)
2017 (10007)
2016 (9161)
2015 (12123)
2014 (9593)
2013 (7715)
2012 (8338)
2011 (8810)
2010 (8642)
Location
Africa (182)
Arizona (47)
Asia (11265)
Australia (1549)
California (841)
Canada (407)
China (24)
Colorado (32)
Connecticut (43)
Europe (23880)
Florida (110)
Georgia (18)
Idaho (23)
Illinois (69)
Indiana (33)
Japan (23)
Kansas (23)
Maine (32)
Maryland (114)
Massachusetts (729)
Michigan (55)
Minnesota (95)
Montana (16)
New Jersey (282)
New York (260)
North Carolina (224)
Northern California (420)
Ohio (32)
Pennsylvania (185)
South America (274)
Southern California (308)
Texas (97)
Utah (24)
Washington State (84)
220,731 Results for "incell corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
PeploBio and IncellDX Partner to Launch the First Long COVID Test in the UK and EU
PeploBio and IncellDX are launching the first laboratory developed test in the UK and EU to help diagnose Long COVID, providing doctors with accurate insights into personalised treatment approaches using the incellKINE Long Hauler Index technology.
April 17, 2024
·
1 min read
Deals
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.
May 28, 2024
·
9 min read
Business
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”) today announced financial results and recent corporate highlights for the first quarter ended March 31, 2024.
May 13, 2024
·
15 min read
Pharm Country
Quest Diagnostics Releases 2023 Corporate Responsibility Report
Quest Diagnostics, a leader in diagnostic information services, released its 2023 Corporate Responsibility Report.
June 27, 2024
·
3 min read
Biotech Bay
Aridis Provides Corporate Update - June 24, 2024
Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.
June 24, 2024
·
8 min read
Genetown
Bruker Corporation to Present at Upcoming June 2024 Investor Conferences
Bruker Corporation announced it will present at the following conferences.
May 31, 2024
·
2 min read
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
Business
OSE Immunotherapeutics Provides Business and Corporate Update
OSE Immunotherapeutics Provides Business and Corporate Update Three pharmaceutical agreements signed during the last three months.
May 30, 2024
·
12 min read
Press Releases
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
November 4, 2024
·
7 min read
BioMidwest
Humanetics Corporation to Present at the 2024 BIO International Convention in San Diego
Humanetics Corporation is presenting a corporate overview and details on its promising lead radioprotective drug candidate, BIO 300, at the prestigious Biotechnology Innovation Organization International Convention in San Diego, CA next week.
May 31, 2024
·
2 min read
1 of 22,074
Next